Similar articles

• Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer.

  Kashihara T, Nakayama Y, Okuma K, Takahashi A, Kaneda T, Katagiri M, Nakayama H, Kubo Y, Ito K, Nakamura S, Takahashi K, Inaba K, Murakami N, Saito T, Okamoto H, Itami J, Kusumoto M, Ohe Y, Igaki H. Kashihara T, et al. Radiother Oncol. 2023 Mar;180:109454. doi: 10.1016/j.radonc.2022.109454. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640944
• PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer.

  Barlesi F, Cho BC, Goldberg SB, Yoh K, Zimmer Gelatti AC, Mann H, Gopinathan A, Bielecka ZF, Newton M, Aggarwal C. Barlesi F, et al. Future Oncol. 2024;20(29):2137-2147. doi: 10.1080/14796694.2024.2354160. Epub 2024 Jul 18. Future Oncol. 2024. PMID: 39023287 Free PMC article.
• Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON).

  Saito G, Oya Y, Taniguchi Y, Kawachi H, Daichi F, Matsumoto H, Iwasawa S, Suzuki H, Niitsu T, Miyauchi E, Yokoi T, Yokoyama T, Uenami T, Sakata Y, Arai D, Okada A, Nagata K, Teraoka S, Kokubo M. Saito G, et al. Lung Cancer. 2021 Nov;161:86-93. doi: 10.1016/j.lungcan.2021.08.019. Epub 2021 Sep 5. Lung Cancer. 2021. PMID: 34543942
• The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis.

  Yang Z, Zhong W, Luo Y, Wu C. Yang Z, et al. BMC Cancer. 2023 Oct 10;23(1):962. doi: 10.1186/s12885-023-11472-3. BMC Cancer. 2023. PMID: 37817073 Free PMC article.
• Safety evaluation of durvalumab for the treatment of non-small-cell lung cancer.

  Shibata Y, Murakami S. Shibata Y, et al. Expert Opin Drug Saf. 2020 Jun;19(6):653-659. doi: 10.1080/14740338.2020.1764936. Epub 2020 May 13. Expert Opin Drug Saf. 2020. PMID: 32357806 Review.